ResourcesGuide

Why Do Wall Street Analysts Rarely Say Sell?

Fewer than 3 in 100 recent analyst ratings were sells. Here is the data, the incentives behind it, and how to read a rating scale that leans so heavily toward buy.

Published Updated 6 min readHow we research

Key takeaways

  • Sell ratings are rare: of 184,007 ratings issued by the 1,191 analysts in Exent’s ranking in the 12 months to Nov 16, 2026, 70.4% were Buy, 26.6% Hold and only 3.0% Sell.
  • The causes are structural: investment banking ties, the need for access to management, trading commissions, career incentives, and analysts choosing to cover stocks they like.
  • Ratings are often relative. A “sell” on many bank scales means “expected to trail the analyst’s other stocks”, not “expected to fall”.
  • Because sells are rare, a downgrade to sell carries more information than another buy. Academic work found sell calls were followed by larger, longer price drift than buys.

Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →

How rare are sell ratings?

Very rare: about one rating in 34 is a sell. In Exent’s data, the 1,191 Wall Street analysts in the ranking issued 184,007 ratings in the 12 months to Nov 16, 2026. That works out to roughly 24 buys for every sell.

RatingRatings issued (12 months)Share
Buy (incl. Outperform, Overweight)129,59270.4%
Hold (incl. Neutral, Equal-weight)48,93326.6%
Sell (incl. Underperform, Underweight)5,4823.0%

Source: Exent’s analyst backtest, 1,191 ranked analysts, statistics as of Nov 16, 2026. Each label is folded into buy, hold or sell, as data providers usually do. Bank-by-bank labels are in what “overweight” means.

Individual banks publish their own mix, because FINRA Rule 2241 requires every rated research report to show the percentage of covered stocks in each buy, hold and sell bucket. In J.P. Morgan’s disclosure as of June 30, 2014, 45% of its global coverage was Overweight, 43% Neutral and 11% Underweight. Bank-wide distributions vary, but buys almost always outnumber sells by a wide margin.

Why don’t analysts issue more sell ratings?

Because the people who pay for, use and react to sell-side research mostly reward optimism. None of these forces requires bad faith. Together they tilt the scale.

  • Investment banking: the bank may want to underwrite the company’s next stock or bond deal, and a sell rating does not help win that business.
  • Access: analysts depend on calls and meetings with company management. A harsh rating can make those harder to get.
  • Commissions: buy ideas generate more trading than sell ideas, because every investor can buy but only holders or short sellers can act on a sell.
  • Career incentives: research has found that optimistic analysts tended to get better job moves, holding accuracy constant.
  • Self-selection: analysts tend to start covering stocks they like and drop the ones they don’t, rather than publish a sell.

What does the research say about analyst optimism?

Several well-known studies point the same way. In Michaely and Womack (1999), stocks recommended by analysts whose bank had just taken the company public did worse than buy recommendations from unaffiliated brokers, before, at and after the recommendation date. Hong and Kubik (2003) found that analysts who were optimistic relative to the consensus were more likely to move to better jobs, even after controlling for accuracy.

McNichols and O’Brien (1997) argued that much of the missing bad news comes from coverage choices: analysts pick up stocks when their view is favorable and stop covering them when it is not, so the negative view never appears as a rating.

Regulators reached a similar conclusion. In the 2003 Global Research Analyst Settlement, ten firms paid roughly $1.4 billion over allegations that investment banking had improperly influenced research. The firms neither admitted nor denied the allegations. The deal forced research to be separated from banking. Our guide to whether analyst ratings are biased covers the conflicts in more detail.

Did the rules after 2002 change anything?

Yes, the mix moved, but buys still dominate. Researchers Barber, Lehavy, McNichols and Trueman (2006) documented that the share of buy ratings fell steadily from mid-2000. They linked it at least partly to NASD Rule 2711, which made brokers publish their ratings distributions. Today FINRA Rule 2241 carries those duties: firms must disclose the distribution and must not pay analysts based on specific investment banking deals.

The same study found something useful for investors. Upgrades to buy from brokers with the fewest buy ratings outperformed upgrades from brokers with the most. A stingy rater’s buy means more.

Does a sell rating mean the stock will fall?

Not necessarily. Many banks rate stocks relative to the analyst’s own coverage list. J.P. Morgan’s published definition of Underweight is a stock expected to underperform the average total return of the analyst’s coverage universe over six to twelve months. A semiconductor stock can be Underweight and still rise, if the other chip stocks rise more.

That also explains part of the rarity. A relative scale only needs a few laggards per list, and analysts can express caution with Hold instead. In practice, many investors treat a Hold from a bank analyst as a polite sell. That is a habit, not a definition.

How should you read ratings when sells are so rare?

Read the change, not the level. A downgrade, a cut to the price target or a drop in coverage often says more than one more buy in a sea of buys. Womack (1996) found that prices kept drifting after recommendation changes: about +2.4% after buys, short-lived, and about −9.1% after sells, lasting around six months.

  • Check the bank’s scale: is the rating relative to a coverage list or absolute?
  • Look at the analyst’s own mix: a buy from someone who rarely says buy carries more weight.
  • Watch downgrades and coverage drops as closely as upgrades.
  • Check the track record: how often did this analyst’s past calls work?

Ranked lists of analysts by past accuracy make the last two checks quicker. See how to read analyst consensus and analyst downgrades explained for next steps.

Exent’s top 50 analysts

Across 988,127 ratings, the average Wall Street analyst’s price target was reached 53.0% of the time: close to a coin flip. The spread between analysts is wide, and 14.4% of the 971 analysts with a measurable record reached 70% or more (Exent data, Nov 16, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

How to read ratings in context with Exent

  1. Stocks Radar tracks thousands of Wall Street analysts and ranks them by past accuracy; each analyst profile shows their price targets and record.
  2. Gems flag stocks where several top‑rated analysts (4★ and above in Exent’s scoring) agree, so a buy is weighed by who issued it.
  3. Insider, congress and 13F “smart money” views give a second angle that does not depend on bank incentives.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

In Exent’s data, 3.0% of the 184,007 ratings issued by the 1,191 ranked analysts in the 12 months to Nov 16, 2026 were Sell. 70.4% were Buy and 26.6% Hold.

Not by definition. A hold usually means the analyst expects the stock to roughly match a reference group. Because sells are so rare, many investors read a hold as a cautious signal.

Investment banking relationships, access to management, trading commissions and career incentives all reward optimism. Analysts also tend to cover stocks they like and drop the ones they don’t.

Sell ratings carry more information because they are rare and costly for the analyst to issue. A classic 1996 study found larger and longer price drift after sell recommendations than after buys.

Yes. Under FINRA Rule 2241, research reports with ratings must show the percentage of covered stocks rated buy, hold and sell, and how many of each were investment banking clients.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.